Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Yamamotoya

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 9, 2025
High Glycemic Variability as a Risk Factor for CKD Progression in Type 2 Diabetes with Mild-to-Moderate Kidney DysfunctionTaro Saigusa, Kentaro Watanabe, Masahiro Takubo, et al.
Journal of Diabetes and Its Complications|August 22, 2025
Pericardial fat pad detected on chest X-ray is closely associated with metabolic dysfunction-associated steatotic liver disease and visceral fat accumulation in patients with type 2 diabetesKentaro Watanabe, Hidenori Nishioka, Masahiro Takubo, et al.
Biochemical and Biophysical Research Communications|April 27, 2024
Prolyl isomerase Pin1 in skeletal muscles contributes to systemic energy metabolism and exercise capacity through regulating SERCA activityYusuke Nakatsu, Yasuka Matsunaga, Mikako Nakanishi, et al.
Frontiers in Cell and Developmental Biology|November 17, 2022
Roles of peptidyl prolyl isomerase Pin1 in viral propagationMachi Kanna, Yusuke Nakatsu, Takeshi Yamamotoya, et al.
Experimental Cell Research|March 11, 2023
Prolyl isomerase Pin1 promotes extracellular matrix production in hepatic stellate cells through regulating formation of the Smad3-TAZ complexShunya Aoyama, Yuri Kido, Mayu Kanamoto, et al.
Diabetology International|January 29, 2025
Acetonemic vomiting: a potential complication of treatment with glucagon-like peptide-1 receptor agonists especially in lean type 2 diabetes patientsMidori Fujishiro, Maiko Nosoko, Jin Ikeda, et al.
International Journal of Molecular Sciences|May 27, 2023
Hepatic Pin1 Expression, Particularly in Nuclei, Is Increased in NASH Patients in Accordance with Evidence of the Role of Pin1 in Lipid Accumulation Shown in Hepatoma Cell LinesMachi Kanna, Yusuke Nakatsu, Takeshi Yamamotoya, et al.
Mediators of Inflammation|July 27, 2018
Protective Effect of Sex Hormone-Binding Globulin against Metabolic Syndrome: <i>In Vitro</i> Evidence Showing Anti-Inflammatory and Lipolytic Effects on Adipocytes and MacrophagesHiroki Yamazaki, Akifumi Kushiyama, Hideyuki Sakoda, et al.
World Journal of Gastroenterology|November 1, 2017
Gastrointestinal symptom prevalence depends on disease duration and gastrointestinal region in type 2 diabetes mellitusMidori Fujishiro, Akifumi Kushiyama, Hiroki Yamazaki, et al.
Scientific Reports|September 18, 2021
Prolyl isomerase Pin1 plays an essential role in SARS-CoV-2 proliferation, indicating its possibility as a novel therapeutic targetTakeshi Yamamotoya, Yusuke Nakatsu, Machi Kanna, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 9, 2025
High Glycemic Variability as a Risk Factor for CKD Progression in Type 2 Diabetes with Mild-to-Moderate Kidney DysfunctionTaro Saigusa, Kentaro Watanabe, Masahiro Takubo, et al.
Journal of Diabetes and Its Complications|August 22, 2025
Pericardial fat pad detected on chest X-ray is closely associated with metabolic dysfunction-associated steatotic liver disease and visceral fat accumulation in patients with type 2 diabetesKentaro Watanabe, Hidenori Nishioka, Masahiro Takubo, et al.
Biochemical and Biophysical Research Communications|April 27, 2024
Prolyl isomerase Pin1 in skeletal muscles contributes to systemic energy metabolism and exercise capacity through regulating SERCA activityYusuke Nakatsu, Yasuka Matsunaga, Mikako Nakanishi, et al.
Frontiers in Cell and Developmental Biology|November 17, 2022
Roles of peptidyl prolyl isomerase Pin1 in viral propagationMachi Kanna, Yusuke Nakatsu, Takeshi Yamamotoya, et al.
Experimental Cell Research|March 11, 2023
Prolyl isomerase Pin1 promotes extracellular matrix production in hepatic stellate cells through regulating formation of the Smad3-TAZ complexShunya Aoyama, Yuri Kido, Mayu Kanamoto, et al.
Diabetology International|January 29, 2025
Acetonemic vomiting: a potential complication of treatment with glucagon-like peptide-1 receptor agonists especially in lean type 2 diabetes patientsMidori Fujishiro, Maiko Nosoko, Jin Ikeda, et al.
International Journal of Molecular Sciences|May 27, 2023
Hepatic Pin1 Expression, Particularly in Nuclei, Is Increased in NASH Patients in Accordance with Evidence of the Role of Pin1 in Lipid Accumulation Shown in Hepatoma Cell LinesMachi Kanna, Yusuke Nakatsu, Takeshi Yamamotoya, et al.
Mediators of Inflammation|July 27, 2018
Protective Effect of Sex Hormone-Binding Globulin against Metabolic Syndrome: <i>In Vitro</i> Evidence Showing Anti-Inflammatory and Lipolytic Effects on Adipocytes and MacrophagesHiroki Yamazaki, Akifumi Kushiyama, Hideyuki Sakoda, et al.
World Journal of Gastroenterology|November 1, 2017
Gastrointestinal symptom prevalence depends on disease duration and gastrointestinal region in type 2 diabetes mellitusMidori Fujishiro, Akifumi Kushiyama, Hiroki Yamazaki, et al.
Scientific Reports|September 18, 2021
Prolyl isomerase Pin1 plays an essential role in SARS-CoV-2 proliferation, indicating its possibility as a novel therapeutic targetTakeshi Yamamotoya, Yusuke Nakatsu, Machi Kanna, et al.
Pageof 5